XML 35 R20.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share As the shares underlying these pre-funded warrants can be issued for little

consideration (an exercise price per share equal to $0.001 per share), these shares are deemed to be issued for purposes of basic earnings per share.

 

 

Year Ended
December 31,

 

 

 

2023

 

 

2022

 

 

 

(In thousands, except share and per share data)

 

Net loss

 

$

(40,326

)

 

$

(87,966

)

Net loss per share, basic and diluted

 

$

(1.64

)

 

$

(6.16

)

Weighted-average number of common shares

 

 

24,619,197

 

 

 

14,285,254

 

Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive The following table provides a summary as of December 31, 2023 and 2022 common share equivalents that were excluded because their inclusion would have been anti-dilutive.

 

 

 

Year Ended
December 31,

 

 

 

2023

 

 

2022

 

 

 

 

 

Stock options outstanding and other equity awards

 

 

14,909,155

 

 

 

5,012,035

 

Common and preferred warrants outstanding

 

 

18,577,332

 

 

 

3,127,121

 

Total

 

 

33,486,487

 

 

 

8,139,156